Where it is registered
Each register with its number of medicines and a few of them.
Spain
AEMPS · 3 medicines
- Boostrix Suspension Inyectable en Jeringa Precargada2 UI + 2,5 µg + 8 µg + 8 µg + 20 UI · suspensión inyectable en jeringa precargada · Glaxosmithkline S.A.
- Infanrix Hexa Polvo y Suspension Para Suspension Inyectable30 UI + 40 UI + 20 µg + 10 µg + 25 µg + 25 µg + 10 µg + 40 U.D. (UNIDADES ANTIGENICAS D) + 8 U.D. (UNIDADES ANTIGENICAS D) + 32 U.D. (UNIDADES ANTIGENICAS D) + 10 µg · polvo y disolvente para suspensión inyectable · Glaxosmithkline Biologicals
- Infanrix Hexa Polvo y Suspension Para Suspension Inyectable30 UI + 40 UI + 0,02 mg + 0,01 mg + 0,025 mg + 0,025 mg + 0,01 mg + 40 U.D. (UNIDADES ANTIGENICAS D) + 8 U.D. (UNIDADES ANTIGENICAS D) + 32 U.D. (UNIDADES ANTIGENICAS D) + 0,01 mg · polvo y disolvente para suspensión inyectable · Glaxosmithkline Biologicals
All medicines with Bordetella pertussis proteina meb externa
Every register, a page at a time. Strengths and packs are on each medicine’s page.
3 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Boostrix Suspension Inyectable en Jeringa PrecargadaCombination | Spain | 2 UI + 2,5 µg + 8 µg + 8 µg + 20 UI | suspensión inyectable en jeringa precargada | Marketed | Glaxosmithkline S.A. |
| Infanrix Hexa Polvo y Suspension Para Suspension InyectableCombination | Spain | 30 UI + 40 UI + 20 µg + 10 µg + 25 µg + 25 µg + 10 µg + 40 U.D. (UNIDADES ANTIGENICAS D) + 8 U.D. (UNIDADES ANTIGENICAS D) + 32 U.D. (UNIDADES ANTIGENICAS D) + 10 µg | polvo y disolvente para suspensión inyectable | Marketed | Glaxosmithkline Biologicals |
| Infanrix Hexa Polvo y Suspension Para Suspension InyectableCombination | Spain | 30 UI + 40 UI + 0,02 mg + 0,01 mg + 0,025 mg + 0,025 mg + 0,01 mg + 40 U.D. (UNIDADES ANTIGENICAS D) + 8 U.D. (UNIDADES ANTIGENICAS D) + 32 U.D. (UNIDADES ANTIGENICAS D) + 0,01 mg | polvo y disolvente para suspensión inyectable | Marketed | Glaxosmithkline Biologicals |
At a glance
- Registers
- 1
- Medicines
- 3
- Companies
- 2



